4073 Results

People

  1. Hudis
    Hudis
  2. Giralt
    Giralt
  3. Gonen
    Gonen
  4. Levine
    Levine
  5. Scher
    Scher
  6. Fong
    Fong
  7. Motzer
    Motzer
  8. Ladanyi
    Ladanyi
  9. Travis
    Travis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)
  7. Department of Pathology and Laboratory Medicine (556)
  8. Center for Hematologic Malignancies (550)
  9. Hematologic Malignancies, Division of (465)
  10. Epidemiology and Biostatistics (464)
  1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • HER2 expression in patients (pts) with surgically resected urothelial cancer at high risk of recurrence screened for the phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy targeting HER2
    Meeting Abstract

    Press, M. F.; O'Donnell, P. H.; Plimack, E. R.; Gomella, L. G.; Quinn, D. I.; Sharma, P.; DeVries, T.; Sims, R. B.; Chen, M.; Bajorin, D. F.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Overall survival results from a phase III study of tivozanib hydrochloride versus sorafenib in patients with renal cell carcinoma
    Meeting Abstract

    Motzer, R. J.; Eisen, T.; Hutson, T. E.; Szczylik, C.; Krygowski, M.; Strahs, A. L.; Esteves, B.; Krivoshik, A. P.; Berkenblit, A.; Nosov, D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Value of NADiA ProsVue on the CAPRA-S nomogram for predicting postprostatectomy clinical recurrence
    Meeting Abstract

    Moul, J. W.; Lilja, H.; Lance, R.; Vessella, R.; McDermed, J. E.; Sarno, M. J.; Adams, T. H.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prediction of pathologic complete response to neoadjuvant chemotherapy in urothelial cancer by genetic determinants of platinum sensitivity
    Meeting Abstract

    O'Donnell, P. H.; Alanee, S.; Cao, H.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Ganshert, C.; Smith, N. D.; Steinberg, G. D.; Offit, K.; Stadler, W. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Relationship between biomarkers and everolimus efficacy in the phase III RECORD-1 trial of patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Oudard, S.; Escudier, B. J.; Thompson, J. A.; Grünwald, V.; Masini, C.; Bracarda, S.; Panneerselvam, A.; Gogov, S.; Chen, D.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Radiologic response (RR) by MRI in patients (pts) with muscle-invasive urothelial cancer (MIUC) undergoing neoadjuvant chemotherapy
    Meeting Abstract

    Qu, A. Q.; Choueiri, T. K.; Jacobus, S. J.; Rosenberg, J. E.; Ramaiya, N. H.; Krajewski, K. M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Long-term survival rates after chemotherapy (CTx) in patients (pts) with nonseminomatous (NS) germ cell tumors (GCT) with teratoma (T)
    Meeting Abstract

    Patil, S.; Feldman, D. R.; Bajorin, D. F.; Motzer, R. J.; Sheinfeld, J.; Tickoo, S.; Reuter, V. E.; Bosl, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Development and internal validation of a prognostic nomogram for overall survival in patients with advanced renal cell carcinoma (aRCC) treated with pazopanib (PAZ)
    Meeting Abstract

    Kattan, M. W.; Chakrabarti, D.; Bhatt, K.; Mehmud, F.; Sternberg, C. N.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Final results of a multicenter, open-label phase II trial of dovitinib (TKI258) in patients with advanced urothelial carcinoma with either mutated or nonmutated FGFR3
    Meeting Abstract

    Milowsky, M. I.; Dittrich, C.; Martinez, I. D.; Jagdev, S.; Millard, F. E.; Sweeney, C.; Bajorin, D. F.; Cerbone, L.; Dunn, R. M.; Sen, P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save